Cathelicidin LL-37 induces inflammatory response of mast cells in rat bladder wall

被引：0
|
作者：
Yang, T-X. [1 ]
Wang, G. [1 ]
Li, J-M. [1 ]
Li, C-Y. [2 ]
Liu, J-H. [1 ]
Li, P. [1 ]
Yang, B-W. [1 ]
Shi, X. [1 ]
Guo, H-X. [1 ]
机构：
[1] Kunming Med Univ, Yunnan Inst Urol, Dept Urol, Affiliated Hosp 2, Kunming, Yunnan, Peoples R China
[2] Kunming Med Univ, Dept Neurol, Affiliated Hosp 2, Kunming, Yunnan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2019年 / 26卷
关键词：
Cathelicidin; Inflammation; Interstitial cystitis; Mast cells;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
70
引用
收藏
页码：55 / 56
页数：2
相关论文
共 50 条
  • [1] The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease
    Sun, Lihua
    Wang, Wensheng
    Xiao, Weidong
    Yang, Hua
    [J]. INFLAMMATORY BOWEL DISEASES, 2016, 22 (08) : 1986 - 1991
  • [2] The LL-37 domain: A clue to cathelicidin immunomodulatory response?
    Leite, Michel Lopes
    Duque, Harry Morales
    Rodrigues, Gisele Regina
    da Cunha, Nicolau Brito
    Franco, Octavio Luiz
    [J]. PEPTIDES, 2023, 165
  • [3] Physiological Relevance of LL-37 Induced Bladder Inflammation and Mast Cells
    Oottamasathien, Siam
    Jia, Wanjian
    Roundy, Lindsi McCoard
    Zhang, Jianxing
    Wang, Li
    Ye, Xiangyang
    Hill, A. Cameron
    Savage, Justin
    Lee, Wong Yong
    Hannon, Ann Marie
    Milner, Sylvia
    Prestwich, Glenn D.
    [J]. JOURNAL OF UROLOGY, 2013, 190 (04): : 1596 - 1602
  • [4] Antimicrobial cathelicidin peptide LL-37 induces NET formation and suppresses the inflammatory response in a mouse septic model
    Hosoda, Hiroshi
    Nakamura, Kaho
    Hu, Zhongshuang
    Tamura, Hiroshi
    Reich, Johannes
    Kuwahara-Arai, Kyoko
    Iba, Toshiaki
    Tabe, Yoko
    Nagaoaka, Isao
    [J]. MOLECULAR MEDICINE REPORTS, 2017, 16 (04) : 5618 - 5626
  • [5] Cathelicidin LL-37 - A central factor in the pathogenesis of inflammatory dermatoses?
    Schauber, J.
    Ruzicka, T.
    Rupec, R. A.
    [J]. HAUTARZT, 2008, 59 (01): : 72 - 74
  • [6] Human-derived cathelicidin LL-37 directly activates mast cells to proinflammatory mediator synthesis and migratory response
    Babolewska, Edyta
    Brzezinska-Blaszczyk, Ewa
    [J]. CELLULAR IMMUNOLOGY, 2015, 293 (02) : 67 - 73
  • [7] Cathelicidin LL-37: A central factor in the pathogenesis of inflammatory dermatoses? [Cathelicidin LL-37: Ein zentraler faktor in der pathogenese entzündlicher dermatosen?]
    Schauber J.
    Ruzicka T.
    Rupec R.A.
    [J]. Der Hautarzt, 2008, 59 (1): : 72 - 74
  • [8] Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease
    Kusaka, S.
    Nishida, A.
    Takahashi, K.
    Bamba, S.
    Yasui, H.
    Kawahara, M.
    Inatomi, O.
    Sugimoto, M.
    Andoh, A.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 191 (01): : 96 - 106
  • [9] Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
    Reinholz, Markus
    Ruzicka, Thomas
    Schauber, Juergen
    [J]. ANNALS OF DERMATOLOGY, 2012, 24 (02) : 126 - 135
  • [10] The Human Cathelicidin, LL-37, Induces Granzyme-mediated Apoptosis in Regulatory T Cells
    Mader, Jamie S.
    Ewen, Catherine
    Hancock, Robert E. W.
    Bleackley, Robert C.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2011, 34 (03) : 229 - 235
12345